Heterogeneity of the resistance to gefitinib treatment in a non‐small cell lung cancer patient with active epidermal growth factor receptor mutation

ανά Xu, Chong‐Rui, Zhong, Wen‐Zhao, Zhou, Qing, Zhang, Xu‐Chao, Yang, Jin‐Ji, Wu, Yi‐Long
Τόπος έκδοσης Thorac Cancer (2016)

Principles of biopsy in suspected lung cancer: priority still based on invasion in the era of targeted therapy?

ανά Chen, Hua-Jun, Yang, Jin-Ji, Xu, Chong-Rui, Lei, Yuan-Yuan, Luo, Dong-Lan, Yan, Hong-Hong, Wu, Yi-Long
Έκδοση 2013

EGFR mutations in early‐stage and advanced‐stage lung adenocarcinoma: Analysis based on large‐scale data from China

ανά Pi, Can, Xu, Chong‐Rui, Zhang, Ming‐feng, Peng, Xiao‐xiao, Wei, Xue‐wu, Gao, Xing, Yan, Hong‐Hong, Zhou, Qing
Τόπος έκδοσης Thorac Cancer (2018)

Feasibility of computed tomography-guided core needle biopsy in producing state-of-the-art clinical management in Chinese lung cancer

ανά Chen, Hua-Jun, Yang, Jin-Ji, Fang, Liang-Yi, Huang, Min-Min, Yan, Hong-Hong, Zhang, Xu-Chao, Xu, Chong-Rui, Wu, Yi-Long
Τόπος έκδοσης Thorac Cancer (2014)

Nedaplatin/Gemcitabine Versus Carboplatin/Gemcitabine in Treatment of Advanced Non-small Cell Lung Cancer: A Randomized Clinical Trial

ανά Yang, Jin-ji, Zhou, Qing, Liao, Ri-qiang, Huang, Yi-sheng, Xu, Chong-rui, Wang, Zhen, Wang, Bin-chao, Chen, Hua-jun, Wu, Yi-long
Έκδοση 2012

Familial association of lung cancer with liver cancer in first-degree relatives

ανά Xu, Chong-Rui, Lin, Huan, Su, Jian, Zhang, Xu-Chao, Huang, Yi-Sheng, Yang, Xue-Ning, Zhou, Qing, Yang, Jin-Ji, Zhong, Wen-Zhao, Wu, Yi-Long
Τόπος έκδοσης Cancer Manag Res (2019)

Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-L...

ανά Wu, Yi-Long, Xu, Chong-Rui, Hu, Cheng-Ping, Feng, Jifeng, Lu, Shun, Huang, Yunchao, Li, Wei, Hou, Mei, Shi, Jian Hua, Märten, Angela, Fan, Jean, Peil, Barbara, Zhou, Caicun
Τόπος έκδοσης Onco Targets Ther (2018)

Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial

ανά Zhou, Qing, Yang, Jin-Ji, Chen, Zhi-Hong, Zhang, Xu-Chao, Yan, Hong-Hong, Xu, Chong-Rui, Su, Jian, Chen, Hua-Jun, Tu, Hai-Yan, Zhong, Wen-Zhao, Yang, Xue-Ning, Wu, Yi-Long
Τόπος έκδοσης J Hematol Oncol (2016)

EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer

ανά Dong, Zhong-Yi, Zhang, Jia-Tao, Liu, Si-Yang, Su, Jian, Zhang, Chao, Xie, Zhi, Zhou, Qing, Tu, Hai-Yan, Xu, Chong-Rui, Yan, Li-Xu, Li, Yu-Fa, Zhong, Wen-Zhao, Wu, Yi-Long
Τόπος έκδοσης Oncoimmunology (2017)

Lung Cancer Treatment Disparities in China: A Question in Need of an Answer

ανά Yang, Lu-Lu, Zhang, Xu-Chao, Yang, Xue-Ning, Yang, Jin-Ji, Wang, Zhen, Chen, Hua-Jun, Yan, Hong-Hong, Xu, Chong-Rui, Guan, Ji-Lin, He, Yan-Yan, Zhong, Wen-Zhao, An, She-Juan, Wu, Yi-Long
Έκδοση 2014

Supraclavicular lymph node incisional biopsies have no influence on the prognosis of advanced non-small cell lung cancer patients: a retrospective study

ανά Dong, Song, Zhao, Ning, Deng, Wei, Sun, Hui-wen, Niu, Fei-yu, Yang, Jin-ji, Zhong, Wen-zhao, Li, Feng, Yan, Hong-hong, Xu, Chong-rui, Zhang, Qiu-yi, Yang, Xue-ning, Liao, Ri-qiang, Nie, Qiang, Wu, Yi-long
Τόπος έκδοσης World J Surg Oncol (2017)

The coexistence of MET over-expression and an EGFR T790M mutation is related to acquired resistance to EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer

ανά Gou, Lan-Ying, Li, An-Na, Yang, Jin-Ji, Zhang, Xu-Chao, Su, Jian, Yan, Hong-Hong, Xie, Zhi, Lou, Na-Na, Liu, Si-Yang, Dong, Zhong-Yi, Gao, Hong-Fei, Zhou, Qing, Zhong, Wen-Zhao, Xu, Chong-Rui, Wu, Yi-Long
Τόπος έκδοσης Oncotarget (2016)

Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma

ανά Sun, Hao, Liu, Si-Yang, Zhou, Jia-Ying, Xu, Jin-Tian, Zhang, Huang-Kai, Yan, Hong-Hong, Huan, Jiao-Jiao, Dai, Ping-Ping, Xu, Chong-Rui, Su, Jian, Guan, Yan-Fang, Yi, Xin, Yu, Rong-Shan, Zhong, Wen-Zhao, Wu, Yi-Long
Τόπος έκδοσης EBioMedicine (2020)

Complex ALK Fusions Are Associated With Better Prognosis in Advanced Non-Small Cell Lung Cancer

ανά Kang, Jin, Zhang, Xu-Chao, Chen, Hua-Jun, Zhong, Wen-Zhao, Xu, Yang, Su, Jian, Zhou, Qing, Tu, Hai-Yan, Wang, Zhen, Xu, Chong-Rui, Yang, Xue-Ning, Chen, Zhi-Hong, Wu, Xue, Zhang, Xian, Shao, Yang, Wu, Yi-Long, Yang, Jin-Ji
Τόπος έκδοσης Front Oncol (2020)

Clinical outcomes of advanced non-small-cell lung cancer patients with EGFR mutation, ALK rearrangement and EGFR/ALK co-alterations

ανά Lou, Na-Na, Zhang, Xu-Chao, Chen, Hua-Jun, Zhou, Qing, Yan, Li-Xu, Xie, Zhi, Su, Jian, Chen, Zhi-Hong, Tu, Hai-Yan, Yan, Hong-Hong, Wang, Zhen, Xu, Chong-Rui, Jiang, Ben-Yuan, Wang, Bin-Chao, Bai, Xiao-Yan, Zhong, Wen-Zhao, Wu, Yi-Long, Yang, Jin-Ji
Τόπος έκδοσης Oncotarget (2016)

Analysis of resistance mechanisms to abivertinib, a third-generation EGFR tyrosine kinase inhibitor, in patients with EGFR T790M-positive non-small cell lung cancer from a phase I...

ανά Zhang, Yi-Chen, Chen, Zhi-Hong, Zhang, Xu-Chao, Xu, Chong-Rui, Yan, Hong-Hong, Xie, Zhi, Chuai, Shao-Kun, Ye, Jun-Yi, Han-Zhang, Han, Zhang, Zhou, Bai, Xiao-Yan, Su, Jian, Gan, Bin, Yang, Jin-Ji, Li, Wen-Feng, Tang, Wei, Luo, Feng Roger, Xu, Xiao, Wu, Yi-Long, Zhou, Qing
Τόπος έκδοσης EBioMedicine (2019)